FDA Home Page | CDRH Home Page | Search | A-Z Index | ||
PMA Final Decisions Rendered for May 2005 |
Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance. Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis.
5/26/05 |
ADVIA Centaur® HBsAg ReadyPack Reagents, ADVIA Centaur® HBsAg Confirmatory ReadyPack Reagents, and ADVIA Centaur® HBsAg Quality Control Material |
Bayer Healthcare, Diagnostics Div. Tarrytown , NY 10591 |
Approval for the ADVIA Centaur® HBsAg ReadyPack Reagents, ADVIA Centaur® HBsAg Confirmatory ReadyPack Reagents, and ADVIA Centaur® HBsAg Quality Control Material: ADVIA Centaur HBsAg Ready Pack Indications for Use: The ADVIA Centaur HBsAg assay is an in vitro immunoassay for the qualitative detection of hepatitis B surface antigen (HBsAg) in human serum and plasma (potassium EDTA, lithium or sodium heparinized) using the ADVIA Centaur® system. The assay may be used in conjunction with other serological and clinical information to diagnose individuals with acute or chronic hepatitis B infections. The assay may also be used to screen for hepatitis B infection in pregnant women to identify neonates who are at risk of acquiring hepatitis B during the perinatal period. ADVIA Centaur HBsAg Confirmatory Ready Pack Indication for use: The ADVIA Centaur® HBsAg Confirmatory assay is an in vitro diagnostic immunoassay for the qualitative confirmation of the presence of hepatitis B surface antigen (HBsAg) in human serum or plasma (EDTA, lithium or sodium heparin) using the ADVIA Centaur® system. The assay is intended to be used to confirm the presence of HBsAg in samples that are repeatedly reactive using the ADVIA Centaur HBsAg assay. ADVIA Centaur® HBsAg Quality Control Material Indications for Use: for monitoring the performance of the HBsAg and HBsAg Confirmatory assays on the ADVIA Centaur® Systems. |
5/3/05 |
DakoCytomation Her2 FISH pharmDX™ Kit |
DakoCytomation Denmark A/S. Glostrup , Denmark DK-2600 |
Approval for the DakoCytomation Her2 FISH pharmDX™ Kit. The device is indicated for: The DakoCytomation Her2 FISH pharmDX™ Kit is a direct fluorescence in situ hybridization (FISH) assay designed to quantitatively determine the Her2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens. Her2 FISH pharmDX™ Kit is indicated as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered. Results form the Her2 FISH pharmDx™ Kit are intended for use as an adjunct to the clinicopathologic information currently used for estimating prognosis in stage II, node positive breast cancer patients. |
5/3/05 |
Duraloc® Option Ceramic Hip System |
DePuy Orthopedics, Inc. Warsaw , IN 46581 |
Approval for the Duraloc® Option Ceramic Hip System. The device is indicated for non-cemented use in primary total hip arthroplasty in skeletally mature patients with non-inflammatory degenerative joint disease (NIDJD) such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and post-traumatic arthritis. |
P790019/S019 5/25/05 Special |
Abbott HAVAB® -M EIA |
Abbott Laboratories Abbott Park , IL 60064 |
Approval for change in quality controls that add a new specification, or otherwise provide additional assurance of purity, identity, strength, or reliability of the Abbott HAVAB® -M EIA assay. |
P860019/S201 5/11/05 135-Day |
Maverick2™ Monorail and Maverick Over-the-Wire PTCA Catheters |
Boston Scientific Maple Grove , MN 55311 |
Approval for change in the manufacturing process for forming the folding the balloon wings from a manual process to an automated process. |
P900056/S084 5/25/05 Special |
Rotablator Rotational Angioplasty System |
Boston Scientific Corp. Maple Grove , MN 55311 |
Approval for an additional quality control (QC) inspection method using the passage of guidewire through the RotaLink PLUS device lumen to verify the device is free from obstructions. |
P910023/S078 5/24/05 Real-Time |
Housecall Plus™ Transtelephonic Monitoring System with Model 3180-R Receiver Software (Version 2.1) |
St. Jude Medical Sunnyvale , CA 94086 |
Approval for the software modifications to the St. Jude Medical Housecall Plus™ Receiver software (version 2.1). |
P920004/S020 5/19/05 180-Day |
VasoSeal® On-Site Precision Closure Device |
Datascope Corporation MahWah , NJ 07430 |
Approval for the VasoSeal® On-Site Precision Closure Device. |
P930016/S022 5/2/05 Real-Time |
STAR S4 IR™ Excimer Laser System |
VISX, Inc. Santa Clara , CA 95051 |
Approval for software and labeling changes regarding the iris registration functionality of the device. |
P930038/S042 5/16/05 135-Day |
Angio-Seal™ Vascular Closure Device |
St. Jude Medical, Inc. Minnetonka , MN 55345 |
Approval for an alternative backup deployment rest methodology. |
P930038/S043 5/12/05 Real-Time |
Angio-Seal™ Vascular Closure Device |
St. Jude Medical, Inc. Minnetonka , MN |
Approval for changing the lot release sampling plan and performance specification. |
P950014/S025 5/25/05 Real-Time |
Urologix Prostatron™ System |
Urologix Minneapolis , MN 55447 |
Approval to modify a voltage tolerance setting and to replace the current software with its previously approved version. |
P950022/S019 5/16/05 Real-Time |
Riata® Defibrillation Leads |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Approval for changes to the stylet ring and the lead header coupling. |
P950037/S035 5/18/05 180-Day |
Implant Control System (ICS) 3000 |
Biotronik, Inc. Lake Oswego , OR 97035 |
Approval for the Implant Control System (ICS) 3000 pacemaker programming system, using software Version 402.U. |
P960040/S053 5/18/05 Real-Time |
Vitality™ HE Model T180 Implantable Cardioverter Defibrillator (ICD) System and the Consult Programmer Software Application Model 2896 Version 1.0 |
Guidant Corporation St. Paul , MN 55112 |
Approval for the Vitality HE Model T180 Implantable Cardioverter Defibrillator (ICD) System and the Consult Programmer Software Application Model 2896 Version 1.0. The device is indicated as follows: Guidant ICDs are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. |
P970004/S032 5/27/05 Special |
Medtronic® InterStim® Sacral Nerve Stimulation™ System |
Medtronic, Inc. Shoreview , MN 55126 |
Approval for the addition of a precaution statement to the technical manual of the Model 8840 N’Vision Programmer regarding the presence of flammable anesthetic agents. |
P980003/S015 5/20/05 Real-Time |
Chilli II Cooled Ablation Catheters |
Boston Scientific Corporation San Jose , CA 95134 |
Approval for an extension of the shelf life from six (6) months to on (1) year; and, packaging changes for the Chilli® II Ablation Catheter. |
P980006/S007 5/27/05 180-Day |
BAUSCH & LOMB® PureVision™ (balafilcon A) Visibility Tinted Contact Lens for Therapeutic Use |
Bausch & Lomb Rochester , NY 14609 |
Approval for adding a therapeutic indication for the PureVision Contact Lens. The device, as modified, will be marketed under the trade name BAUSCH & LOMB® PureVision™ (balafilcon A) Visibility tinted Contact Lens for Therapeutic Use and is indicated for therapeutic use as a bandage contact lens for corneal protection and corneal pain relief during treatment of ocular pathologies as well as post-surgical conditions. Applications of the PureVision Contact Lens include but are not limited to conditions such as the following: 1) For corneal protection in conditions such as entropion, trichiasis, tarsal scars, recurrent corneal erosion and post surgical ptosis for corneal protection; 2) For corneal pain relief in conditions such as bullous keratopathy, epithelial erosion and abrasion, filamentary keratitis, post-keratoplasty; 3) For use as a bandage during the healing process of conditions such as chronic epithelial defects, corneal ulcer, neurotrophic keratitis, neuroparalytic keratitis, chemical burns, and post surgical epithelial defects; and 4) For post surgical conditions that include bandage use such as LASIK, PRK, PK, PTK, lamellar grafts, corneal flaps, and additional corneal surgical conditions. Pure Vision Contact Lenses for therapeutic use can also provide correction during healing if required. |
P980006/S008 5/27/05 Real-Time |
BAUSCH & LOMB® PureVision™ Multi-Focal (balafilcon A) Visibility Tinted Contact Lenses |
Bausch & Lomb Rochester , NY 14609 |
Approval for a multifocal design of the BAUSCH & LOMB® PureVision™ Visibility Tinted Contact Lenses and is indicated for daily wear or extended wear from 1 to 30 days between removals, for cleaning and disinfection or disposal of the lens, as recommended by the eye care professional. The lens is indicated for the correction of refractive ametropia (myopia, hyperopia and astigmatism) and presbyopia in aphakic and/or not-aphakic persons with non-diseased eyes, exhibiting astigmatism of 2.00 diopters or less, that does not interfere with visual acuity. The lens may be prescribed for Frequent/Planned Replacement Wear or Disposable Wear in spherical powers ranging from +6.00D to -18.00D when prescribed for up to 30 days of extended wear and from +20.00 to -20.00 for daily wear or extended wear up to 7 days with add powers ranging from +0.75 to +5.00D. |
P980053/S009 5/25/05 180-Day |
Durasphere® Injectable Bulking Agent |
Carbon Medical Technologies, Inc. St. Paul , MN 55110 |
Approval for inclusion of the 5-year post-market study information in the Directions for Use. |
P990004/S008 5/5/05 Real-Time |
Surgiflo Hemostatic Matrix |
Johnson & Johnson Wound Management Somerville , NJ 08876 |
Approval for marketing a pre-filled paste prepared from the powdered form of the absorbable gelatin sponge. The device, as modified, will be marketed under the trade name SURGIFLO Hemostatic Matrix and is indicated for surgical procedures (except urologic and ophthalmic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical. |
P990066/S019 5/25/05 Real-Time |
Senographe DS Full Field Digital Mammography System |
GE Healthcare Waukesha , WI 53188 |
Approval for changes in two software modifications that have been made to the acquisition workstation (AWS) and for an additional supplier for the conditioner (chiller for the image receptor). The device, as modified, will be marketed under the trade name Senographe DS Full Field Digital Mammography System and is indicated as follows: The Senographe DS Full Field Digital Mammography System generates digital mammographic images that can be used for screening and diagnosis of breast cancer. The Senographe DS Full Field Digital Mammography System is intended to be used in the same clinical applications as traditional film-based mammographic system. |
P000044/S006 5/5/05 Special |
VITROS Immunodiagnostic Products HBsAg Reagent Pack and Calibrator, and the VITROS Immunodiagnostic Products HBsAg Confirmatory Kit |
Ortho-Clinical Diagnostic, Inc. Rochester , NY 14626 |
Approval for changes in the manufacturing process which add an incoming raw material test. |
P010014/S002 5/27/05 Real-Time |
Oxford Meniscal Unicompartmental Knee System |
Biomet Manufacturing Corp. Warsaw , IN 46581 |
Approval for design modifications to the tibial baseplate. |
P010032/S013 5/11/05 Real-Time |
S-Series Lamitrode Leads |
Advanced Neuromodulation Systems, Inc. Plano , TX 75024 |
Approval for the addition of four models of the S-Series Lamitrode Leads as accessories to the Genesis family of Neurostimulation IPG devices. The device, as modified, will be marketed under the trade name S-Series Lamitrode leads (model numbers3243, 3246, 3283 and 3286) and is indicated for use as the lead component of a spinal cord stimulation system. The spinal cord stimulation system is used to aid in the management of chronic pain of the trunk and/or extremities. |
P010032/S016 5/5/05 Real-Time |
Genesis Dual 4-Channel Implantable Pulse Generator (IPG), Model 3643 |
Advanced Neuromodulation Systems, Inc. Plano , TX 75024 |
Approval for the Genesis Dual 4-Channel Implantable Pulse Generator (IPG), Model 3643 which is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain and leg pain. |
P020004/S010 5/10/05 135-Day |
GORE EXCLUDER® Bifurcated Endoprosthesis, Contralateral Leg Component, Trunk-Ipsilateral Leg Component, Aortic Extender Component and Iliac Extender Component |
W.L. Gore & Associates, Inc. Flagstaff , AZ 86001 |
Approval for the addition of a new cleanroom and controlled environment area. |
P020026/S011 5/20/05 180-Day |
CYPHER Sirolimus-eluting Coronary Stent |
Cordis Corporation |
Approval for an analytical testing laboratory located at Pharmaceutical Sourcing Group Americas (PSGA), also known as Janssen Pharmaceuticals, Inc., Titusville, New Jersey. |
P020031/S001 5/25/05 180-Day |
Microsulis Microwave Endometrial Ablation (MEA) System |
Microsulis Medical Ltd. 02451 |
Approval for the single use MEA applicator. |
P030024/S003 5/5/05 Special |
VITROS Immunodiagnostic Products Anti-HBc Reagent Pack and Calibrator |
Ortho-Clinical Diagnostics, Inc. Rochester , NY 14626 |
Approval for the addition of an incoming raw material test. |
P030025/S007 5/19/05 Real-Time |
TAXUS Express 2 Paclitaxel-Eluting Coronary Stent System |
Boston Scientific Corporation Natick , MA 01760 |
Approval for extension of the product shelf life from 9 months to 12 months. |
P030030/S002 5/27/05 180-Day |
Bard® Tegress™ Urethral Implant |
C.R. Bard, Inc. Covington , GA 30014 |
Approval for a manufacturing site at Bard Shannon Ltd., Las Piedras, Puerto Rico , 00771. |
P030034/S001 5/16/05 Real-Time |
Cervical-Stim® Cervical Fusion System |
Orthofix, Inc. McKinney , TX 75069 |
Approval for the following modifications: 1) The Power Source has been changed from a 9 volt disposable lithium battery to an 11.1 volt rechargeable lithium battery. 2) The user interface has been changed from three color LED indicators to a Liquid Crystal Display. 3) The drive circuit and microprocessor were previously located on separate pc boards. The modified device incorporates both components on the same pc board. 4) Optional Accessory: Personal Data Assistant (PDA) for Orthofix personal use only. 5) The connection between the device and the compliance printer has changed from a serial port cable to an infrared port. The device, as modified, will be marketed under the trade name Cervical-Stim® Model 2505 and is indicated for: “The Cervical-Stim® Model 2505 Cervical Fusion System is a noninvasive, pulsed electromagnetic bone growth stimulator indicated as an adjunct to cervical fusion surgery in patients at high risk for non-fusion.” |
P860057/S028 5/20/05 |
Carpentier-Edwards® PERIMOUNT® Pericardial Bioprosthesis, Models 2700, 2700TFX, 2800, 2800TFX, 2900, 3000, 3000TFX, 6900, 2900P (PERIMOUNT Plus™), 6900PTFX |
Edwards Lifesciences LLC Irvine , CA 92614 |
Change in the supplier of polyethylene terephthalate (PET) polyester yarn and knitted polyester fabric. |
P870056/S021 5/20/05 |
Carpentier-Edwards® Bioprosthesis, Models 2625, 6625 |
Edwards Lifesciences LLC Irvine , CA 92614 |
Change in the supplier of polyethylene terephthalate (PET) polyester yarn and knitted polyester fabric. |
P870077/S019 5/20/05 |
Carpentier-Edwards® Duraflex® Low Pressure Bioprosthesis, Models 6625LP, 6625-ESR-LP |
Edwards Lifesciences LLC Irvine , CA 92614 |
Change in the supplier of polyethylene terephthalate (PET) polyester yarn and knitted polyester fabric. |
5/19/05 |
Exogen 2000+ Sonic Accelerated Fracture Healing System (SAFHS) and Exogen 3000 Sonic Accelerated Fracture Healing System (SAFHS) |
Smith & Nephew, Inc. Memphis , TN 38116 |
Addition of a new contract vendor for the supply of components/ materials used in the manufacturing process. |
P910023/S079 5/9/05 |
St. Jude ICDs |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Alternate process for removing epoxy from the connector block threaded bores of the ICD devices. |
P950022/S020 5/5/05 |
Riata Family of Defibrillation Leads |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Dimensional changes to the Riata leads. |
P950022/S021 5/5/05 |
Riata Family of Defibrillation Leads |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Change from welding to crimping connectors. |
P950022/S022 5/5/05 |
Riata Family of Defibrillation Leads |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Change from manual to automated processing. |
P950022/S023 5/5/05 |
Riata Family of Defibrillation Leads |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Change in the order of manufacturing steps for the crimping process. |
P960006/S015 5/6/05 |
FLEXTEND Leads, Models 4086, 4087, and 4088 |
Guidant Corporation St. Paul , MN 55112 |
Change of silicone adhesive. |
P980049/S019 5/13/05 |
Alto SHOCK 4 Modules |
ELA Medical, Inc. Plymouth , MN 55441 |
Changes to the manufacturing process at International Rectifier, Leominster , Massachusetts and Thales, Neuilly-sur-Seine , France . The modifications include: 1) changing the epoxy resin for encapsulation 2) removing the Parylene coating 3) changing the photocoupler and discharge circuits form separate components to a single component coated with epoxy 4) changing the epoxy for attaching the transformer, and 5) adding a silicone cover over certain capacitors prior to the final assembly process. |
P000007/S008 5/20/05 |
Edwards Prima Plus Stentless Bioprosthesis, Model 2500, 2500P |
Edwards Lifesciences LLC Irvine , CA 92614 |
Change in the supplier of polyethylene terephthalate (PET) polyester yarn and knitted polyester fabric. |
P000014/S012 5/25/05 |
VITROS Immunodiagnostic Products Anti-HBs Reagent Pack and Calibrators |
Ortho-Clinical Diagnostics, Inc. Rochester , NY 14626 |
Change in scale of reagent manufacturing. |
P000032/S009 5/26/05 |
Her Option™ Cryoablation Therapy System |
American Medical Systems Minnetonka , MN 55343 |
Addition of a new type of filter to the cryostat, change to enhance the corrosion resistance of the cryostat tubing, change in the cryostat cleaning method. |
P000037/S004 5/4/05 |
On-X® Prosthetic Heart Valve |
MCRI Austin , TX 78754 |
Change in the manufacturing process to include an additional standard leaflet inspection step for reworked product with unacceptably high leak test result. |
P010041/S008 5/20/05 |
Carpentier-Edwards® Supraannular (S.A.V.®) Bioprosthesis, Model 2650, 6650 |
Edwards Lifesciences LLC Irvine , CA 92614 |
Change in the supplier of polyethylene terephthalate (PET) polyester yarn and knitted polyester fabric. |
P030012/S001 5/25/05 |
R2 ImageChecker CT CAD Software System |
R2 Technology, Inc. Sunnyvale , CA 94087 |
Alternate manufacturing process for the R2 ImageChecker CT product lines. |
P030054/S009 5/9/05 |
St. Jude ICDs |
St. Jude Medical, Inc. Sunnyvale , CA 94086 |
Alternate process for removing epoxy from the connector block threaded bores of the ICD devices. |
P040043/S001 5/10/05 |
GORE TAG Thoracic Endoprosthesis |
W.L. Gore & Associates, Inc. Flagstaff , AZ 86001 |
Addition of a new cleanroom and controlled environment area. |
P040043/S002 5/20/05 |
GORE TAG Thoracic Endoprosthesis |
W.L. Gore & Associates, Inc. Flagstaff , AZ 86001 |
Change from a hand assembly process to a semi-automated process in the assembly of the delivery catheter. |
P040043/S003 5/27/05 |
GORE TAG Thoracic Endoprosthesis |
W.L. Gore & Associates, Inc. Flagstaff , AZ 86001 |
Expansion of the controlled manufacturing environment at Woody Springs . |
P040043/S004 5/27/05 |
GORE TAG Thoracic Endoprosthesis |
W.L. Gore & Associates, Inc. Flagstaff , AZ 86001 |
Expansion of the controlled manufacturing environment at Elk Hill. |
Summary of PMA Originals & Supplements Approved
Originals: 3
Supplements: 30
Summary of PMA Originals Under Review
Total Under Review: 82
Total Active: 35
Total On Hold: 47
Number Greater Than 180 Days: 3
Summary of PMA Supplements Under Review
Total Under Review: 258
Total Active: 125
Total On Hold: 133
Number Greater Than 180 Days: 7
Summary of All PMA Submissions Received
Originals: 2
Supplements: 55
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 30
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 111.0
FDA Time: 80.3 Days MFR Time: 30.7 Days
Updated June 4, 2007
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH